Foundationone Heme
Device Oncology
General payments
$1,785,481
Research payments
$1,454,125
Through program year 2022, $1,785,481 in general payments and $1,454,125 in research payments were reported against Foundationone Heme (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $56,647 | 1,893 |
| 2022 | Research | $647,500 | 1 |
| 2021 | General | $49,864 | 1,339 |
| 2021 | Research | $800,000 | 13 |
| 2020 | General | $564,394 | 1,902 |
| 2020 | Research | $3,500 | 3 |
| 2019 | General | $1,114,576 | 2,953 |
| 2019 | Research | $3,125 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
8,087 general · 18 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.